Clinical Trial Update: Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis [Phase 2]

View source ↗

Summary

A Phase II trial evaluated two dosing regimens of MN-001 in patients with interstitial cystitis and reports on efficacy and safety. The study is completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• MN-001

Snippet

Sponsor: MediciNova | Conditions: Interstitial Cystitis | Phase 2 | Status: COMPLETED | Results posted: 2012-01-19